Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation

Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH).

Exclusive: BioNTech acquires lipid nanoparticle startup founded by George Mason and UPenn scientists

BioNTech, the German drug company famous for developing a Covid-19 vaccine with Pfizer, has acquired AexeRNA and its novel lipid nanoparticles for mRNA medicines, Endpoints

November 4, 2023

Dozens of Deaths Show Risks of Injecting Sedatives Into People Restrained by Police

The practice of giving sedatives to people detained by police spread quietly across the nation over the last 15 years, built on questionable science and

April 28, 2024

Study urges sub-Saharan Africa to embrace diverse crops for nutritional security

Farmers in sub-Saharan Africa need to diversify away from growing maize and switch to crops that are resilient to climate change and supply enough key

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.